Lecithin pp 137-146 | Cite as

The Therapeutic Value of Phosphatidylserine Effect in the Aging Brain

  • Gino Toffano
Part of the Advances in Behavioral Biology book series (ABBI, volume 33)


As the elucidation of the biological roles of membrane phospholipids has progressed, a new field of investigation dealing with the pharmacological effects of these compounds has become possible (Table 1). Cellular membranes in addition to their property of delimiting compartments, are endowed with surface recognition sites which, in specialized instances, yield the means of offense and defense reactions (Bruni and Toffano, 1982). The administration of phospholipid liposomes has been shown to activate blood clotting (Zwaal, 1978), complement pathways (Cunningham et al., 1979; Richards et al., 1979) and phagocytosis (Hudson et al., 1979; Wu et al., 1981). In addition, the exogenous phospholipids may enter the pathways of phospholipid metabolism yielding a number of short-lived compounds showing powerful regulation effects on biological and physiopathological phenomena. These products can be named lipid autacoid drugs since they are active drugs made in the organism itself.


Nerve Growth Factor Passive Avoidance Passive Avoidance Test Active Avoidance Test Dendritic Spine Loss 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aporti, F., Borsato, R., Calderini, G., Rubini, R., Toffano, G., Zanotti, A., Valzelli, L., and Goldstein, L, 1985, Age-dependent spontaneous EEG bursts in rats: effects of brain phosphatidylserine, Neurobiol. Aging, 7:115.CrossRefGoogle Scholar
  2. Battistella, A., Mietto, L., Toffano, G., Palatini, P., Bigon, E., and Bruni, A., 1985, Synergism between lysophosphatidylserine and the phorbol ester tetradecanoylphorbolacetate in rat mast cells, Life Sci., 36:1581.PubMedCrossRefGoogle Scholar
  3. Besedovsky, H.O., Del Rey, A.E., and Sorkin, E., 1983, What do the immune system and the brain know about each other?, Immunology Today, 44:342.CrossRefGoogle Scholar
  4. Boarato, E., Mietto, L., Toffano, G., and Bruni A., 1986, Uptake of phosphatidylserine vesicles by rat leukocytes, Biochim. Biophys. Acta, submitted.Google Scholar
  5. Bruni, A., Bigon, E., Boarato, E., Mietto, L., Leon, A., and Toffano, G., 1982, Interaction between nerve growth factor and lysophosphatidylserine on rat peritoneal mast cells, FEBS Letters, 138:190.PubMedCrossRefGoogle Scholar
  6. Bruni, A., and Palatini, P., 1982, Biological and Pharmacological Properties of Phospholipids, Progr. Med. Chem., 19:111.CrossRefGoogle Scholar
  7. Bruni, A., and Toffano, G., 1982, The principles of Phospholipid Pharmacology, in: “Transport in Biomembranes: Models Systems and Reconstitution,” R. Antolini, et al., eds., Raven Press, New York.Google Scholar
  8. Bruni, A., Mietto, L., Battistella, A., Boarato, E., Palatini, P., and Toffano, G., 1986, Serine phospholipids in cell communication, in: “Phospholipids Research and the Nervous System: Biochemical and Molecular Pharmacology,” L.A. Horrocks, L. Freysz, and G. Toffano, eds., Liviana Press, Padova (Italy).Google Scholar
  9. Calderini, G., Teolato, S., Bonetti, A.C., Battistella, A., and Toffano, G, 1981, Effect of lyso-phosphatidylserine on rat hypothalamic cAMP, in vivo, Life Sci., 28:2367.PubMedCrossRefGoogle Scholar
  10. Calderini, G., Bellini, F., Bonetti, A.C., Galbiati, E., Rubini, R., Zanotti, A., and Toffano, G., 1986, Pharmacological properties of phosphatidylserine in the aging brain: biochemical aspects and therapeutic potential, in: “Phospholipids Research and the Nervous System: Biochemical and Molecular Pharmacology,” L.A. Horrocks, L. Freysz, and G. Toffano, eds., Liviana Press, Padova (Italy).Google Scholar
  11. Casamenti, F., Mantovani, P., Amaducci, L., and Pepeu, G., 1979, Effect of phosphatidylserine on acetylcholine output from the cerebral cortex of the rat, J. Neurochem., 32:529.PubMedCrossRefGoogle Scholar
  12. Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., and Nishizuka, Y., 1982, Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters, J. Biol. Chem., 257:7847.PubMedGoogle Scholar
  13. Corwin, J., Dean, R.L., Bartus, R.T., Rotrosen, J., and Watkins, D.L., 1985, Behavioral effects of phosphatidylserine in the aged Fischer 344 rat: amelioration of passive avoidance deficits without changes in psychomotor task performance, Neurobiol. Aging, 6:11.PubMedCrossRefGoogle Scholar
  14. Cunningham, C.M., Kingzette, M., Richards, R.L., Alving, C.R., Lint, T.F., and Gewurz, H., 1979, Activation of human complement by liposomes: a model for membrane activation of the alternative pathway, J. Immunol., 122:1237.PubMedGoogle Scholar
  15. Drago, F., Canonico, P.L., and Scapagnini, U., 1981, Behavioral effects of phosphatidylserine in aged rats, Neurobiol. Aging, 2:209.PubMedCrossRefGoogle Scholar
  16. Franck, P.F.H., Chin, D.T.Y, Opden Kamp J.A.F., Lubin, B., Van Deenen, L.L.M., and Roelofsen, B, 1983, Accelerated transbilayer movement of phosphatidylcholine in sickled erythrocytes, J. Biol. Chem., 258:8436.PubMedGoogle Scholar
  17. Gordesky, S.E., and Marinetti, G.V., 1973, The asymetrie arrangement of phospholipids in the human erythrocyte membrane, Biochim. Biophys. Res. Commun., 50:1027.CrossRefGoogle Scholar
  18. Gray, J.A., and McNaughton, N., 1983, Comparison between the behavioural effects of septal and hippocampal lesions: a review, Neurosci. Biobehav. Reviews, 7:119.CrossRefGoogle Scholar
  19. Hudson, L.D.S., Fiddler, M.B., and Desnick, R.J., 1979, Enzyme therapy. X. Immune response induced by enzyme-and buffer-loaded liposomes in C3H/HeJ GuSh mice, J. Pharmacol. Exp. Ther., 208:507.PubMedGoogle Scholar
  20. Mazzari, S., and Battistella, A., 1980, Phosphatidylserine effects on dopamine release from striatum synaptosomes, in: “Multidisciplinary approach to brain development,” C. Di Benedetta, R. Balàzs, G. Gombos, and G. Porcellati, eds., Elsevier, North-Holland.Google Scholar
  21. Murphy, K.M.M., Gould, R.J., Oster-Granite, M.L., Gearhart, J.D., and Snyder, S.H., 1983, Phorbol ester receptors: autoradiographic identification in the developing rat, Science (New York), 222:1036.CrossRefGoogle Scholar
  22. Nishizuka, Y., 1984, The role of protein kinase C in cell surface signal transduction and tumor promotion, Nature (London), 308:693.CrossRefGoogle Scholar
  23. Nunzi, M.G., Milan, F., Guidolin, D., and Toffano, G., 1986, Dendritic spine loss in hippocampus of aged rats. Effects of brain phosphatidylserine administration, Neurobiol. Aging, Submitted.Google Scholar
  24. Op dem Kamp, J.A., 1979, Lipid asymmetry in membranes, Ann. Rev. Biochem., 48:47.CrossRefGoogle Scholar
  25. Palatini, P., Dabbeni-Sala, F., and Bruni, A., 1972, Reactivation of a phospholipid-depleted sodium, potassium-stimulated ATPase, Biochim. Biophis. Acta, 288:413.CrossRefGoogle Scholar
  26. Papahadjopoulus, D., 1978, Calcium-induced phase changes and fusion in natural and model membranes, in: “Membrane Fusion,” G. Poste, and G.L. Nicolson, eds, Elsevier, North Holland, Amsterdam.Google Scholar
  27. Pedata, F., Giovannelli, L., Spignoli, G., Giovannini, M.G., and Pepeu, G., 1985, Phosphatidylserine increases acetylcholine release from cortical slices in aged rats, Neurobiol. Aging, 6:337.PubMedCrossRefGoogle Scholar
  28. Pepeu, G., Gori, G., and Bartolini, L., 1980, Pharmacologic and therapeutic perspectives on dementia: an experimental approach, in: “Aging of the brain and dementia”, eds., L. Amaducci, A.N. Davison, and P. Antuono, eds., Raven Press, New York.Google Scholar
  29. Richards, R.L., Gewurz, H., Siegel, J., and Alving, C.R., 1979, Interactions of C-reactive protein and complement with liposomes, II. Influence of membrane composition, J. Immunol., 122:1185.PubMedGoogle Scholar
  30. Sbaschnig-Agler, M., and Pullarkat, R.K., 1985, Lysophosphatidylserine dependent incorparation of acylCoA into phospholipids in rat brain microsomes, Neurochem. Int., 7:295.PubMedCrossRefGoogle Scholar
  31. Sundler, R., Duzgunes, N., and Papahadjopoulos, D., 1981, Control of membrane fusion by phosholipid head groups. II. The role of phosphatidylethanolamine in mixtures with phosphatidate and phosphati-dylinositol, Biochim. Biophys. Acta., 649:751.PubMedCrossRefGoogle Scholar
  32. Toffano, G., Leon, A., Mazzari, S., Savoini, G., Teolato, S., and Orlando, P., 1978, Modification of noradrenergic hypothalamic system in rat injected with phosphatidylserine liposomes, Life Sci., 23:1093.PubMedCrossRefGoogle Scholar
  33. Toffano, G., and Bruni, A., 1980, Pharmacological properties of phospholipid liposomes, Pharm. Res. Commun., 12:829.CrossRefGoogle Scholar
  34. Verkleij, A.J, Zwaal, R.F., Roelofsen, B., Comfurius P., Kastelijn D., and van Deenen, L.L.M., 1973, The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy, Biochim. Biophys. Acta., 323:178.PubMedCrossRefGoogle Scholar
  35. Wu, P.S., Tin, G.W., and Baldeschwieler, J.D., 1981, Phagocytosis of carbohydrate-modified phospholipid vesicles by macrophage, Proc. Natl. Acad. Sci. USA, 78:2033.PubMedCrossRefGoogle Scholar
  36. Zanotti, A., Aporti, F., Toffano, G., and Valzelli, L., 1984, Effects of phosphatidylserine on avoidance relearning in rats (Preliminary observations), Pharm. Res. Commun., 16:485.CrossRefGoogle Scholar
  37. Zanotti, A., Valzelli, L., and Toffano, G., 1986, Partial reversal of scopolamine-induced amnesia by phosphatidylserine in rats, European J. Pharm., in press.Google Scholar
  38. Zwall, R.F.A., 1978, Membrane and lipid environment in blood coagulation, Biochim. Biophysic. Acta, 515:163.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Gino Toffano
    • 1
  1. 1.Fidia Neurobiological Research LaboratoriesAbano TermeItaly

Personalised recommendations